85 results on '"Van Laere, Koen"'
Search Results
2. Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor
3. Mild Motor Signs in Healthy Aging Are Associated with Lower Synaptic Density in the Brain
4. Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease
5. Longitudinal Synaptic Density PET with 11C‐UCB‐J 6 Months After Ischemic Stroke
6. Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET
7. Development, initial validation, and application of a visual read method for [ 18 F]MK‐6240 tau PET
8. The novel M4 PAM PET tracer [11C] MK‐6884: a novel biomarker for measuring target engagement of muscarinic M4 positive allosteric modulators (PAMs) as well as cholinergic tone in patients with Alzheimer’s disease
9. Weighted Gene Co‐Expression Network Analysis for peripheral whole‐blood RNA sequencing in asymptomatic Alzheimer’s disease
10. 18 F‐MK6240 tau in ento‐ and perihinal cortex is related to episodic memory in the earliest stages of Alzheimer’s disease
11. Predictive value of a plasma p‐tau181‐specific assay for amyloid accumulation in asymptomatic Alzheimer’s Disease
12. Longitudinal Positron Emission Tomography Imaging of Presynaptic Terminals in Early Parkinson's Disease
13. Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease
14. Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study
15. Lack of association between bridging integrator 1 (BIN1) rs744373 polymorphism and tau-PET load in cognitively intact older adults
16. Longitudinal changes in the brain language system as amyloid accumulates
17. Parkinson's Disease with a HomozygousPARK7Mutation and Clinical Onset at the Age of 5 Years
18. Differential involvement of limbic and paralimbic cortex in episodic memory processing in cognitive aging and neurodegeneration
19. Longitudinal changes in [ 18 F]Flutemetamol load in cognitively intact APOE ε4 carriers vs noncarriers: Comparison of three reference regions
20. Regional distribution of amyloid deposition and grey matter atrophy in late‐life depression
21. Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
22. Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies
23. Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study
24. O5‐07‐02: APOLIPOPROTEIN E AND BIN1 POLYMORPHISMS DIFFERENTIALLY AFFECT CORTICAL AMYLOID AND TAU LOAD IN HEALTHY OLDER ADULTS
25. IC-P-003: THE CAPTAINS STUDY: STANDARDIZING VISUAL INTERPRETATION STRATEGIES FOR AMYLOID PET TRACERS
26. IC-P-150: [C-11]MK-6884 PET: CHARACTERIZING BRAIN M4 RECEPTORS IN HEALTHY ELDERLY VOLUNTEERS AND ACETYLCHOLINESTERASE INHIBITORS-TREATED AD PATIENTS
27. Development of temporal lobe epilepsy during maintenance electroconvulsive therapy: A case of human kindling?
28. IC‐P‐068: A POLYGENIC AD RISK SCORE PREDICTS AMYLOID ACCUMULATION OVER A 6‐YEAR INTERVAL IN COGNITIVELY INTACT OLDER ADULTS
29. O3‐10‐03: A POLYGENIC AD RISK SCORE PREDICTS AMYLOID ACCUMULATION OVER A 6‐YEAR INTERVAL IN COGNITIVELY INTACT OLDER ADULTS
30. Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18 F‐FPEB and 1 H‐MRS study in rats
31. Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys
32. Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers
33. Moral processing deficit in behavioral variant frontotemporal dementia is associated with facial emotion recognition and brain changes in default mode and salience network areas
34. Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study
35. [IC-P-177]: FIRST EVALUATION OF THE NEUROFIBRILLARY TANGLES RADIOLIGAND [18 F]MK-6240 IN ALZHEIMER's DISEASE PATIENTS
36. [P3-381]: FIRST EVALUATION OF THE NEUROFIBRILLARY TANGLES RADIOLIGAND [18 F]MK-6240 IN ALZHEIMER's DISEASE PATIENTS
37. [P3-385]: VISUAL READING OF AMYLOID-PET IN MCI CHALLENGED: SHOULD WE CONSIDER ALTERNATIVE METHODS?
38. IN VIVO VISUALIZATION OF [18]F-THK5351 BINDING IN PRIMARY PROGRESSIVE APHASIA
39. Brain PET imaging of phosphodiesterase 10A in progressive supranuclear palsy and Parkinson's disease
40. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP
41. IC-P-187: Discovery and First-in-Human Evaluation of the TAU-imaging PET Radiotracer [18 F]MK-6240
42. P1-350: 3D-Shape Perception in Amnestic Mild Cognitive Impairment
43. P1‐246: Discovery and First‐in‐Human Evaluation of the TAU‐Imaging PET Radiotracer [18F]MK‐6240
44. IC‐P‐173: Utility of PMOD Image Quantification Software for Processing [ 11 C]PIB and [ 18 F]Flutemetamol Images for SUVR Quantitation on The Centiloid Scale
45. Functional integration changes in regional brain glucose metabolism from childhood to adulthood
46. Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer18F-FPEB in human brain
47. O2-10-03: In vivo characterization of basal forebrain atrophy and cholinergic denervation in primary progressive aphasia
48. Functional brain changes underlying irritability in premanifest Huntington's disease
49. Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans
50. O1-07-06: COMPARISON OF 18F-FLUTEMETAMOL UPTAKE AND CSF MEASUREMENTS IN COGNITIVELY INTACT OLDER INDIVIDUALS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.